Literature DB >> 11688207

[Epidemiology of soft tissue sarcomas in adults].

N Penel1, C Nisse, S Feddal, E Lartigau.   

Abstract

INCIDENCE: Soft tissue sarcoma accounts for a approximately 1% of all cancers. Excluding Kaposi sarcoma, the incidence of soft tissue sarcoma has remained stable in Europe (3-4/100,000). ENDOGENOUS FACTORS: Endogenous factors are related to rare genetic syndromes (Li-Fraumeni syndrome, neurofibromatosis, Werner syndrome, bilateral retinoblastom). EXOGENOUS FACTORS: Exogenous factors associated with soft tissue sarcoma are essentially iatrogenic: radiation therapy (prevalence of radiation-induced sarcoma: 0.17-0.21%) and chronically edematous arms after radical mastectomy for breast cancer (Stewart-Treves syndrome). Many studies suggest that environmental or occupational exposure to chlorophenol, phenoxy-herbicides or dioxin increase the risk of soft tissue sarcoma. FURTHER RESEARCH: Little is known about the epidemiology of soft tissue sarcoma. Case-control studies are needed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11688207

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  7 in total

1.  Efficacy and safety of sorafenib in a subset of patients with advanced soft tissue sarcoma from a Phase II randomized discontinuation trial.

Authors:  Simon Pacey; Mark J Ratain; Keith T Flaherty; Stanley B Kaye; Lisa Cupit; Eric K Rowinsky; Chenghua Xia; Peter J O'Dwyer; I R Judson
Journal:  Invest New Drugs       Date:  2009-12-18       Impact factor: 3.850

2.  Radiation-induced osteosarcoma of the maxilla and mandible after radiotherapy for nasopharyngeal carcinoma.

Authors:  Lie-Qiang Liao; Hong-Hong Yan; Jun-Hao Mai; Wei-Wei Liu; Hao Li; Zhu-Ming Guo; Zong-Yuan Zeng; Xue-Kui Liu
Journal:  Chin J Cancer       Date:  2016-10-12

3.  Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States.

Authors:  Santiago Zuluaga-Sanchez; Lisa M Hess; Sorrel E Wolowacz; Yulia D'yachkova; Emma Hawe; Adrian D Vickers; James A Kaye; David Bertwistle
Journal:  Sarcoma       Date:  2018-03-26

4.  Osteosarcoma following single fraction radiation prophylaxis for heterotopic ossification.

Authors:  Michael K Farris; Varun K Chowdhry; Sheila Lemke; Mary Kilpatrick; Michael Lacombe
Journal:  Radiat Oncol       Date:  2012-08-21       Impact factor: 3.481

5.  Postirradiation osteosarcoma of the maxilla: a case report and current review of literature.

Authors:  Imene Chabchoub; Olfa Gharbi; Sami Remadi; Sami Limem; Amel Trabelsi; Makrem Hochlef; Leila Ben Fatma; Amel Landolsi; Moncef Mokni; Chekib Kraiem; Slim Ben Ahmed
Journal:  J Oncol       Date:  2009-05-25       Impact factor: 4.375

6.  Cost effectiveness of first-line treatment with doxorubicin/ifosfamide compared to trabectedin monotherapy in the management of advanced soft tissue sarcoma in Italy, Spain, and sweden.

Authors:  Julian F Guest; Monica Panca; Erikas Sladkevicius; Nicholas Gough; Mark Linch
Journal:  Sarcoma       Date:  2013-11-03

Review 7.  [Pulmonary synovial sarcoma: case study and literature review].

Authors:  Onana Remy; Mohammed Messouna; Gloria Akimana; Marius Kamdem; Hassan Errihani
Journal:  Pan Afr Med J       Date:  2020-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.